The current standard of staging Hepatitis C patients is through liver biopsies. There are many issues with liver biopsies including accuracy, cost, injury, and how often they can be performed. There is tremendous need for non-invasive methods for staging liver disease and this paper will delve into some of the systems that have already been developed. Many of these new methods are also expensive and contain proprietary algorithms.